28Jul 2023
Clinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression)

Clinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression)

The study analyzed 684 patients from European trials and found high p53 expression combined with MIPI-c predicts poor prognosis. The high-risk group showed significantly shorter median failure-free survival (FFS) and overall survival (OS) compared to the low-risk group. Validation cohorts supported findings. A current treatment may not be sufficient for high-risk patients, prompting the need for innovative approaches

  • #oncology

Like

Save

Share